Assistant Professor Ting Fu and collaborators have identified a promising new target for treatments that could help the millions of people worldwide who suffer from inflammatory bowel disease and related colorectal cancers.

Assistant Professor Ting Fu and collaborators have identified a promising new target for treatments that could help the millions of people worldwide who suffer from inflammatory bowel disease and related colorectal cancers.
Armed with two new grants, School of Pharmacy Assistant Professor Jason Peters continues his quest to find new targets for the hardest-to-treat bacterial infections.
New research by School of Pharmacy Professor Lingjun Li uncovers the role of neuropeptides in post-traumatic stress disorder.
For his innovative research of natural products, Associate Professor Jason Kwan is being nationally recognized by the American Society of Pharmacognosy.
School of Pharmacy Assistant Professor Heather Barkholtz is working to deepen our understanding of new drugs of abuse and how to detect them.
A new antiviral compound designed and synthesized by researchers at the University of Wisconsin–Madison’s School of Pharmacy is highly effective in mice against two types of devastating encephalitis viruses that are harmful to humans.
Assistant Professor Quanyin Hu has developed a new method for targeting tumors with cancer drugs by exploiting the clotting propensity of blood platelets.
From COVID-19 to encephalitic alphaviruses, School of Pharmacy Associate Professor Jennifer Golden and collaborators are developing new antiviral treatments.
Associate Professor Jason Kwan launches a new course to help undergraduates explore soil microbes and build hands-on skills in bioinformatics.
Postdoctoral scientist Sarah Neuman and Professor Arash Bashirullah find bridge-shaped proteins that channel the flow of essential lipids inside cells.